PTH


Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia, Wikipedia.

PTH

PTH

abbr.
parathyroid hormone

PTH

Abbreviation for parathyroid hormone.

Parathyroid hormone (PTH)

A chemical substance produced by the parathyroid glands. This hormone is a major element in regulating calcium in the body.
Mentioned in: Hypercalcemia
References in periodicals archive ?
Results from Part 1 of this study, reported in 2018, demonstrated a positive impact of Oral PTH on three metabolic parameters - serum calcium, phosphate, and 1,25-dihydroxyvitamin D ('active' vitamin D) - in patients with hypoparathyroidism.
Statistical correlation between scintigraphic parameters and three biochemical parameters (serum PTH, and calcium and phosphor levels) were evaluated.
In osteoporotic patients, 86.66% of patients had low vitamin D and 66.67% patients had raised PTH, while in osteopenic patients 68.75% had low vitamin D and 37.50% had raised PTH (p value= 0.002).
In view of the patient's normal intelligence, lack of features of Albright hereditary osteodystrophy (AHO) other than considerations of overweight and short stature, and the hormonal resistance limited to PTH, PHP type 1b was suspected.
They said that the PTH representatives argued that it was a trust and couldn't run a hospital owned by the provincial government.
The brown colored PTh powder was obtained after drying under vacuum at 70[degrees]C for 48 h.
Group I (control) followed the normal culture conditions and 3 nM and 30 nM PTH (CIHR Matrix Dynamics, University of Toronto, Canada) were added to Groups II and III, respectively.
The first laboratory examination revealed normal serum calcium (9.7 mg/dL) and phosphorus (5.3 mg/dL) levels, with an elevated serum PTH (138.1 pg/mL) level.
PTH (Beckman Coulter, Fullerton Ca), 25OHD (DiaSorin Inc., Stillwater, MN), plasma renin activity (DiaSorin, Stillwater, MN) and serum aldosterone (Siemens, Los Angeles, CA), serum and urinary electrolytes (including total and ionized calcium and phosphate), and urinary aldosterone excretion were measured at each study visit.
Previous research has explored factors that may increase the risk of developing PTH, but our study investigates only recurrent PTH.
Based on previous studies that were mentioned above, it is expected that intermittent PTH could stimulate the bone regeneration after maxillary sinus augmentation.
OVX rats were further split into three groups: a group undergoing a preventive treatment with human PTH (1-34) (prevention group), a group treated with PTH after osteopenia was developed (therapeutic treatment group), and a nontreated group.